Hint mode is switched on Switch off

GeneDx Holdings, ordinary share
WGS, US81663L2007

Add a stock to WL
Choose all Reset all
GeneDx Holdings, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
GeneDX Holdings Corp. operates as a patient-centered health intelligence company. The Company focuses on AI and machine learning to multidimensional, longitudinal clinical, and genomic data to build dynamic models of human health and individualized health trajectories.
  • Issuer
  • Full borrower / issuer name
    GeneDx Holdings Corp
  • Industry
    Medical Services

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    WGS
  • Placement
    30.01.2023
  • Lock up period
    180
  • Number of papers
    810,000,334
  • Volume of raised funds
    115 mln USD
  • Placement share
    40.56%
  • Final placement price
    0.35 USD
  • Price change since placement date
    16,760%
  • By capitalization
    283.5 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

15/06/2026 GeneDx Holdings: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
13/04/2026 GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
27/02/2026 GeneDx Holdings: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant
23/02/2026 INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
03/02/2026 GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.